Geode Capital Management’s TriSalus Life Sciences TLSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.11M Buy
777,094
+25,887
+3% +$127K ﹤0.01% 2955
2025
Q4
$5.25M Buy
751,207
+196,752
+35% +$1.1M ﹤0.01% 2743
2025
Q3
$2.58M Buy
554,455
+99,404
+22% +$465K ﹤0.01% 3099
2025
Q2
$2.48M Buy
455,051
+235,627
+107% +$1.26M ﹤0.01% 3069
2025
Q1
$1.21M Buy
219,424
+15,287
+7% +$81.4K ﹤0.01% 3239
2024
Q4
$1.02M Buy
204,137
+3,710
+2% +$15.7K ﹤0.01% 3371
2024
Q3
$924K Buy
200,427
+62,542
+45% +$331K ﹤0.01% 3382
2024
Q2
$761K Buy
137,885
+3,786
+3% +$32.1K ﹤0.01% 3411
2024
Q1
$1.31M Buy
134,099
+8,337
+7% +$77K ﹤0.01% 3260
2023
Q4
$1.06M Buy
125,762
+108,523
+630% +$559K ﹤0.01% 3337
2023
Q3
$88.3K Hold
17,239
﹤0.01% 4288
2023
Q2
$181K Hold
17,239
﹤0.01% 4087
2023
Q1
$176K Hold
17,239
﹤0.01% 4115
2022
Q4
$173K Hold
17,239
﹤0.01% 4175
2022
Q3
$171K Hold
17,239
﹤0.01% 4298
2022
Q2
$169K Hold
17,239
﹤0.01% 4369
2022
Q1
$168K Sell
17,239
-1,367
-7% -$13.5K ﹤0.01% 4458
2021
Q4
$183K Hold
18,606
﹤0.01% 4516
2021
Q3
$184K Hold
18,606
﹤0.01% 4484
2021
Q2
$181K Buy
18,606
+1,341
+8% +$13.1K ﹤0.01% 4376
2021
Q1
$166K Buy
+17,265
New +$175K ﹤0.01% 4172

Other funds holding TLSI

Geode Capital Management's TLSI Position: Q1 2026 in Review

Geode Capital Management increased its TriSalus Life Sciences (TLSI) stake by 3.4% in Q1 2026, buying an estimated $127K and bringing the position to 777,094 shares worth $3.11M. The position accounts for ﹤0.01% of the portfolio, ranked #2955.

Geode Capital Management first reported a position in TLSI in Q1 2021 and has held it in 21 quarters since. The position peaked at $5.25M in Q4 2025. 84 funds tracked by Wall St. Rank hold TLSI as of Q1 2026.

  • Geode Capital Management held 777,094 shares of TriSalus Life Sciences worth $3.11M as of Q1 2026.
  • Geode Capital Management bought 25,887 TriSalus Life Sciences shares in Q1 2026, an estimated $127K.
  • TriSalus Life Sciences made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #2955 holding.
  • Geode Capital Management first reported a position in TriSalus Life Sciences in Q1 2021 and has held it in 21 quarters since.
  • Geode Capital Management's TriSalus Life Sciences position peaked at $5.25M in Q4 2025.
  • 84 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.